Leveraged & Inverse Channel Direxion Launches New Nanotechnology ETF, TYNE By Aaron NeuwirthNovember 23, 2021
Innovative ETFs Channel A Specialty Biotech ETF Strengthens on Optimism Over CRISPR Advancements By Max ChenMarch 1, 2019